Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Furin

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 16, 2016
Update in Tuberculosis/Pulmonary Infections 2015Serena P Koenig, Jennifer Furin
Lancet (London, England)|August 14, 2018
Providing quality care on the border with HaitiSerena P Koenig, Jennifer Furin
Lancet (London, England)|March 25, 2019
TuberculosisJennifer Furin, Helen Cox, Madhukar Pai
Science (New York, N.Y.)|March 27, 2025
Equitable access needed in clinical researchGisa Dang, Christophe Perrin, Jennifer Furin
The Lancet. Infectious Diseases|May 24, 2017
Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?Amber Kunkel, Jennifer Furin, Ted Cohen
Plos One|December 21, 2020
"Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosisMarian Loveday, Sindisiwe Hlangu, Jennifer Furin
The European Respiratory Journal|November 11, 2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosisJennifer Furin, Erica Lessem, Vivian Cox
The Lancet. Respiratory Medicine|September 10, 2017
Bedaquiline or delamanid for rifampin-resistant tuberculosis?Erica Lessem, Vivian Cox, Jennifer Furin
Current Opinion in HIV and AIDS|November 9, 2018
Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIVJustine Fargher, Anja Reuter, Jennifer Furin
Lancet (London, England)|September 19, 2019
Challenges and controversies in childhood tuberculosisAnja Reuter, Jennifer Hughes, Jennifer Furin
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
American Journal of Respiratory and Critical Care Medicine|July 16, 2016
Update in Tuberculosis/Pulmonary Infections 2015Serena P Koenig, Jennifer Furin
Lancet (London, England)|August 14, 2018
Providing quality care on the border with HaitiSerena P Koenig, Jennifer Furin
Lancet (London, England)|March 25, 2019
TuberculosisJennifer Furin, Helen Cox, Madhukar Pai
Science (New York, N.Y.)|March 27, 2025
Equitable access needed in clinical researchGisa Dang, Christophe Perrin, Jennifer Furin
The Lancet. Infectious Diseases|May 24, 2017
Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?Amber Kunkel, Jennifer Furin, Ted Cohen
Plos One|December 21, 2020
"Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosisMarian Loveday, Sindisiwe Hlangu, Jennifer Furin
The European Respiratory Journal|November 11, 2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosisJennifer Furin, Erica Lessem, Vivian Cox
The Lancet. Respiratory Medicine|September 10, 2017
Bedaquiline or delamanid for rifampin-resistant tuberculosis?Erica Lessem, Vivian Cox, Jennifer Furin
Current Opinion in HIV and AIDS|November 9, 2018
Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIVJustine Fargher, Anja Reuter, Jennifer Furin
Lancet (London, England)|September 19, 2019
Challenges and controversies in childhood tuberculosisAnja Reuter, Jennifer Hughes, Jennifer Furin
Pageof 16